Researchers from the University of California San Diego School of Medicine have described a new approach that uses artificial intelligence […]
Experts has developed a mobile application and secure patient data storage platform – FDA MyStudies – to address privacy, engagement […]
In a lengthy statement released on Wednesday, FDA staff appeared to endorse Biogen’s treatment for Alzheimer’s disease. If approved, this […]
In a recent study published in Therapeutic Innovation and Regulatory Science, researchers conducted a systematic review of the decision factors […]
Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.
Lung cancer is one of the leading causes of cancer death among men and women in the US. One option […]
Contrary to prior clinical trials, researchers have revealed that metastatic urothelial cancer patients with fibroblast growth factor receptor (FGFR) mutations […]
A recent phase II study used real-world evidence to assess responses to a combination treatment of atezolizumab and bevacizumab in […]
Researchers have demonstrated that an in-silico approach, using virtual patient data, was able to replicate clinical trial results and investigate […]
Earlier this week the U.S. Food and Drug Administration approved the first new treatment for Alzheimer’s disease in almost 20 […]
